NCT00432861View on ClinicalTrials.gov

Evaluation of the Safety and Efficacy of Pancrecarb® MS-16 in Cystic Fibrosis

PHASE3CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions
Cystic FibrosisPancreatic Insufficiency
Interventions
DRUG

PANCRECARB® (pancrelipase)

Capsules

DRUG

Placebo

Capsules

Trial Locations (1)

44106

Rainbow Babies and Children's Hospital, Cleveland

All Listed Sponsors
lead

Digestive Care, Inc.

INDUSTRY

NCT00432861 - Evaluation of the Safety and Efficacy of Pancrecarb® MS-16 in Cystic Fibrosis | Biotech Hunter | Biotech Hunter